SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Jensen Huang is gonewhat happens to the US$500 billion financing platform? The "pillar of trust" underpinning NVIDIA Corporation (NVDA.US)'s AI credit platform is collapsing.
Douyin E-commerce wraps up "Double 11": over 20,000 small and medium-sized merchants exceed RMB1 million in sales
The AI feast is not over yet! Anthropic (ANT.US) IPO is six times oversubscribed and is expected to surpass SpaceX to become the "largest IPO in history."
Jensen Huang is gonewhat happens to the US$500 billion financing platform? The "pillar of trust" underpinning NVIDIA Corporation (NVDA.US)'s AI credit platform is collapsing.
Douyin E-commerce wraps up "Double 11": over 20,000 small and medium-sized merchants exceed RMB1 million in sales
The AI feast is not over yet! Anthropic (ANT.US) IPO is six times oversubscribed and is expected to surpass SpaceX to become the "largest IPO in history."
